Pregabalin kan medføre afhængighed og abstinenssymptomer
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Pregabalin kan medføre afhængighed og abstinenssymptomer. / Nordgaard, Julie; Jürgens, Gesche.
I: Ugeskrift for Laeger, Bind 177, Nr. 2A, 2015, s. 38-9.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Pregabalin kan medføre afhængighed og abstinenssymptomer
AU - Nordgaard, Julie
AU - Jürgens, Gesche
PY - 2015
Y1 - 2015
N2 - A 38-year-old man was referred to the psychiatric department due to auditory hallucinations, suicidal ideation and a large daily intake of 8.4 g pregabalin. The Danish National Medication Register showed that the patient had bought pregabalin 21 times within the last two months, a total of 487.2 g pregabalin. Withdrawal symptoms disappeared within 48 hours, psychotic experiences and the suicidal ideations faded during the next couple of weeks. High doses of pregabalin are tolerated with surprisingly few toxicological consequences, though lethal cases have been described. Pregabalin abuse, however, can lead to dependency.
AB - A 38-year-old man was referred to the psychiatric department due to auditory hallucinations, suicidal ideation and a large daily intake of 8.4 g pregabalin. The Danish National Medication Register showed that the patient had bought pregabalin 21 times within the last two months, a total of 487.2 g pregabalin. Withdrawal symptoms disappeared within 48 hours, psychotic experiences and the suicidal ideations faded during the next couple of weeks. High doses of pregabalin are tolerated with surprisingly few toxicological consequences, though lethal cases have been described. Pregabalin abuse, however, can lead to dependency.
KW - Adult
KW - Anti-Anxiety Agents
KW - Anxiety
KW - Hallucinations
KW - Humans
KW - Male
KW - Pregabalin
KW - Substance Withdrawal Syndrome
KW - Substance-Related Disorders
KW - Suicidal Ideation
KW - Case Reports
M3 - Tidsskriftartikel
C2 - 25612958
VL - 177
SP - 38
EP - 39
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 2A
ER -
ID: 187624237